181 related articles for article (PubMed ID: 36263643)
1. DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia.
Aytac HM; Oyaci Y; Pehlivan M; Pehlivan S
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):685-693. PubMed ID: 36263643
[TBL] [Abstract][Full Text] [Related]
2. Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters.
Oyaci Y; Aytac HM; Pasin O; Cetinay Aydin P; Pehlivan S
J Addict Dis; 2021; 39(4):526-536. PubMed ID: 33781176
[TBL] [Abstract][Full Text] [Related]
3. The relationship of the methylation status and polymorphism of glucocorticoid receptor gene (
Oyaci Y; Yildirim YE; Aytac HM; Pehlivan S; Aydin PC
J Investig Med; 2024 Jun; 72(5):449-456. PubMed ID: 38494341
[TBL] [Abstract][Full Text] [Related]
4. Methylation of APC2, NR3C1, and DRD2 gene promoters in turkish patients with tobacco use disorder.
Halit C; Elif YN; Hasan MA; Sacide P; Yasemin O; Deniz D; Mehmet AU
Niger J Clin Pract; 2022 Feb; 25(2):160-166. PubMed ID: 35170441
[TBL] [Abstract][Full Text] [Related]
5. Catechol-O-methyltransferase gene promoter methylation as a peripheral biomarker in male schizophrenia.
Gao S; Cheng J; Li G; Sun T; Xu Y; Wang Y; Du X; Xu G; Duan S
Eur Psychiatry; 2017 Jul; 44():39-46. PubMed ID: 28545007
[TBL] [Abstract][Full Text] [Related]
6. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI
Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829
[TBL] [Abstract][Full Text] [Related]
7. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM
J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670
[TBL] [Abstract][Full Text] [Related]
8. Impact of Social Defeat Stress on DNA Methylation in Drd2, Nr3c1, and Stmn1 in Wild-type and Stmn1 Knock-out Mice.
Oh YE; Nguyen TB; Rami FZ; Karamikheirabad M; Chung YC
Clin Psychopharmacol Neurosci; 2022 Feb; 20(1):51-60. PubMed ID: 35078948
[TBL] [Abstract][Full Text] [Related]
9. Potential link between genetic polymorphisms of
Han J; Li Y; Wang X
Neuropsychiatr Dis Treat; 2017; 13():2935-2943. PubMed ID: 29255361
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Profiles of the DRD2 and NR3C1 Genes in Patients with Recent-Onset Psychosis.
Piao YH; Cui Y; Li L; Karamikheirabad M; Kim SW; Lee BJ; Kim JJ; Yu JC; Lee KY; Won SH; Lee SH; Kim SH; Kang SH; Kim E; Kang NI; Rami FZ; Chung YC
Dis Markers; 2022; 2022():2172564. PubMed ID: 35968502
[TBL] [Abstract][Full Text] [Related]
11. Clinical Correlates of the NR3C1 Gene Methylation at Various Stages of Psychosis.
Misiak B; Samochowiec J; Konopka A; Gawrońska-Szklarz B; Beszłej JA; Szmida E; Karpiński P
Int J Neuropsychopharmacol; 2021 Apr; 24(4):322-332. PubMed ID: 33284958
[TBL] [Abstract][Full Text] [Related]
12. Risperidone Induced DNA Methylation Changes in Dopamine Receptor and Stathmin Genes in Mice Exposed to Social Defeat Stress.
Rami FZ; Nguyen TB; Oh YE; Karamikheirabad M; Le TH; Chung YC
Clin Psychopharmacol Neurosci; 2022 May; 20(2):373-388. PubMed ID: 35466108
[TBL] [Abstract][Full Text] [Related]
13. NURR1 and ERR1 Modulate the Expression of Genes of a
Torretta S; Rampino A; Basso M; Pergola G; Di Carlo P; Shin JH; Kleinman JE; Hyde TM; Weinberger DR; Masellis R; Blasi G; Pennuto M; Bertolino A
J Neurosci; 2020 Jan; 40(4):932-941. PubMed ID: 31811028
[TBL] [Abstract][Full Text] [Related]
14. Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects.
Yoshino Y; Kawabe K; Mori T; Mori Y; Yamazaki K; Numata S; Nakata S; Yoshida T; Iga J; Ohmori T; Ueno S
World J Biol Psychiatry; 2016 Sep; 17(6):449-56. PubMed ID: 27269479
[TBL] [Abstract][Full Text] [Related]
15. Global and glucocorticoid receptor gene-specific (NR3C1) DNA methylation analysis in patients with cannabinoid or synthetic cannabinoid use disorder.
Pehlivan S; Aytac HM; Cetinay Aydin P; Nursal AF; Pehlivan M
Psychiatry Res; 2021 Apr; 298():113774. PubMed ID: 33556690
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-Methyltransferase (COMT) Gene (Val158Met) and Brain-Derived Neurotropic Factor (BDNF) (Val66Met) Genes Polymorphism in Schizophrenia: A Case-Control Study.
Saravani R; Galavi HR; Lotfian Sargazi M
Iran J Psychiatry; 2017 Oct; 12(4):265-270. PubMed ID: 29472953
[No Abstract] [Full Text] [Related]
17. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
18. Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia.
Kordi-Tamandani DM; Sahranavard R; Torkamanzehi A
Psychiatr Genet; 2013 Oct; 23(5):183-7. PubMed ID: 23851595
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S
Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.
van der Knaap LJ; Schaefer JM; Franken IH; Verhulst FC; van Oort FV; Riese H
Genes Brain Behav; 2014 Sep; 13(7):618-25. PubMed ID: 24902721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
